Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Clasificación en acciones #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Precio por acción
$0.5099
Última sincronización: 2024-10-15
Capitalización bursátil
$7.60M
Cambio (1 día)
2.02%
Cambio (1 año)
0.00%
País
US
Comercio Anew Medical, Inc. (WENA)

Categoría

EPS de Anew Medical, Inc. (WENA)
EPS a fecha de June 2024 TTM: $0.00
Según los últimos informes financieros y el precio de las acciones de Anew Medical, Inc., el EPS actual de la empresa (TTM) es $0.00. Al final del año 2022, la empresa tenía un EPS de $0.08 un aumento con respecto a al EPS de 2021, que fue de $-0.09.
Historial de EPS de Anew Medical, Inc. desde 2021 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE